Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Dolichyl-diphosphooligosaccharide–protein glycosyltransferase subunit STT3B (STT3B) is a catalytic enzyme subunit of the oligosaccharyltransferase (OST) complex found in the endoplasmic reticulum membrane of eukaryotic cells[1][2][3][4][5]. Its main function is to catalyze the transfer of preassembled oligosaccharide chains from dolichyl-diphosphooligosaccharide donors onto asparagine residues within nascent polypeptides, a process called N-linked glycosylation[1][2][4]. Humans express two closely related OST catalytic subunits, STT3A and STT3B, which are assembled into distinct OST complexes and differ in substrate specificity and timing (co- vs post-translational modification)[1]. STT3B, in particular, mediates post-translational glycosylation of sites skipped by STT3A and acts independently of association with the protein translocation channel[1]. Mutations in STT3B can lead to congenital disorders of glycosylation and impact multiple systems due to insufficient protein glycosylation. STT3B is essential for proper protein folding and cell viability and represents a prototypical member of the glycosyltransferase family of enzymes that regulate glycoprotein expression, with implications in inherited and acquired disease[2][4].
For potential or research inhibitors (e.g., tunicamycin): Inhibition of N-linked glycosylation by blocking dolichyl-diphosphooligosaccharide access or transfer activity of OST. Disruption of glycoprotein biosynthesis, leading to unfolded protein stress, ER stress, and apoptosis in susceptible cells.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dolichyl-diphosphooligosaccharide–protein glycosyltransferase subunit STT3B (STT3B).